D Arecca James Insider Trades

Insider Trading History

Track insider trading activity for D Arecca James. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Haemonetics
Haemonetics HAE
Evp, Chief Financial Officer
Holding Value $1.76M 25,132 shares
Last Trade
May 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$141k 2,505 shares
$56.29
$69.85
Haemonetics
Haemonetics HAE
Evp, Chief Financial Officer
Holding Value $3.8M 54,444 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 29,312 shares
$56.29
$69.85
Haemonetics
Haemonetics HAE
Evp, Chief Financial Officer
Holding Value $1.93M 27,637 shares
Last Trade
May 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.8k 655 shares
$59.26
$69.85
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $248k 123,830 shares
Last Trade
Aug 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.15M 93,337 shares
$44.50
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $434k 217,167 shares
Last Trade
Aug 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.98M 217,167 shares
$45.96
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $869k 434,333 shares
Last Trade
Aug 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.98M 217,167 shares
$45.96
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
CFO
Holding Value $347k 173,333 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 173,333 shares
$60.50
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
CFO
Holding Value $693k 346,667 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21M 346,667 shares
$60.50
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $303k 151,500 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.09M 151,500 shares
$60.00
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $1.3M 651,500 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1M 651,500 shares
$60.00
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $1.3M 651,500 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1M 651,500 shares
$60.00
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Chief Financial Officer
Holding Value $303k 151,500 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.09M 151,500 shares
$60.00
$2.00
Allergan plc
Allergan plc AGN
SVP Chief Accounting Officer
Holding Value $0 10,552 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
Chief Accounting Officer
Holding Value $0 5,600 shares
Last Trade
Mar 08, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
Chief Accounting Officer
Holding Value $0 5,679 shares
Last Trade
Mar 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
Chief Accounting Officer
Holding Value $0 3,983 shares
Last Trade
Mar 07, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
Chief Accounting Officer
Holding Value $0 4,076 shares
Last Trade
Mar 05, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
Chief Accounting Officer
Holding Value $0 4,146 shares
Last Trade
Mar 02, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
CHIEF ACCOUNTING OFFICER
Holding Value $0 4,222 shares
Last Trade
Dec 29, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Allergan plc
Allergan plc AGN
CHIEF ACCOUNTING OFFICER
Holding Value $0 0 shares
Last Trade
Oct 26, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up